193 related articles for article (PubMed ID: 28284817)
21. Effects of common anesthetics on eye movement and electroretinogram.
Nair G; Kim M; Nagaoka T; Olson DE; Thulé PM; Pardue MT; Duong TQ
Doc Ophthalmol; 2011 Jun; 122(3):163-76. PubMed ID: 21519880
[TBL] [Abstract][Full Text] [Related]
22. Xylazine-/diazepam-ketamine and isoflurane differentially affect hemodynamics and organ injury under hemorrhagic/traumatic shock and resuscitation in rats.
Bahrami S; Benisch C; Zifko C; Jafarmadar M; Schöchl H; Redl H
Shock; 2011 Jun; 35(6):573-8. PubMed ID: 21330949
[TBL] [Abstract][Full Text] [Related]
23. Effects of isoflurane, fentanyl, or thiopental anesthesia on regional cerebral blood flow and brain surface PO2 in the presence of a focal lesion in rabbits.
Murr R; Schürer L; Berger S; Enzenbach R; Peter K; Baethmann A
Anesth Analg; 1993 Nov; 77(5):898-907. PubMed ID: 8214725
[TBL] [Abstract][Full Text] [Related]
24. Differential involvement of D1 and D2 dopamine receptors in L-DOPA-induced angiogenic activity in a rat model of Parkinson's disease.
Lindgren HS; Ohlin KE; Cenci MA
Neuropsychopharmacology; 2009 Nov; 34(12):2477-88. PubMed ID: 19606087
[TBL] [Abstract][Full Text] [Related]
25. Subanesthetic concentration of sevoflurane increases regional cerebral blood flow more, but regional cerebral blood volume less, than subanesthetic concentration of isoflurane in human volunteers.
Lorenz IH; Kolbitsch C; Hörmann C; Schocke M; Felber S; Zschiegner F; Hinteregger M; Kremser C; Pfeiffer KP; Benzer A
J Neurosurg Anesthesiol; 2001 Oct; 13(4):288-95. PubMed ID: 11733659
[TBL] [Abstract][Full Text] [Related]
26. Serum biochemical values of adult ostriches (Struthio camelus) anesthetized with xylazine, ketamine, and isoflurane.
Al-Sobayil FA; Omer OH
J Avian Med Surg; 2011 Jun; 25(2):97-101. PubMed ID: 21877446
[TBL] [Abstract][Full Text] [Related]
27. Distinctive effect of anesthetics on the effect of limb remote ischemic postconditioning following ischemic stroke.
Chen G; Kamat PK; Ahmad AS; Doré S
PLoS One; 2020; 15(1):e0227624. PubMed ID: 31945776
[TBL] [Abstract][Full Text] [Related]
28. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease.
Henry B; Crossman AR; Brotchie JM
Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768
[TBL] [Abstract][Full Text] [Related]
29. Influence of equianaesthetic concentrations of nitrous oxide and isoflurane on regional cerebral blood flow, regional cerebral blood volume, and regional mean transit time in human volunteers.
Lorenz IH; Kolbitsch C; Hörmann C; Luger TJ; Schocke M; Felber S; Zschiegner F; Hinteregger M; Kremser C; Benzer A
Br J Anaesth; 2001 Nov; 87(5):691-8. PubMed ID: 11878518
[TBL] [Abstract][Full Text] [Related]
30. Alterations in cortical and basal ganglia levels of opioid receptor binding in a rat model of l-DOPA-induced dyskinesia.
Johansson PA; Andersson M; Andersson KE; Cenci MA
Neurobiol Dis; 2001 Apr; 8(2):220-39. PubMed ID: 11300719
[TBL] [Abstract][Full Text] [Related]
31. Basal ganglia serotonin 1B receptors in parkinsonian monkeys with L-DOPA-induced dyskinesia.
Riahi G; Morissette M; Samadi P; Parent M; Di Paolo T
Biochem Pharmacol; 2013 Oct; 86(7):970-8. PubMed ID: 23954709
[TBL] [Abstract][Full Text] [Related]
32. Antidyskinetic effect of A2A and 5HT1A/1B receptor ligands in two animal models of Parkinson's disease.
Pinna A; Ko WK; Costa G; Tronci E; Fidalgo C; Simola N; Li Q; Tabrizi MA; Bezard E; Carta M; Morelli M
Mov Disord; 2016 Apr; 31(4):501-11. PubMed ID: 26871939
[TBL] [Abstract][Full Text] [Related]
33. Visualisation of changes in regional cerebral blood flow (rCBF) produced by ketamine using long TE gradient-echo sequences: preliminary results.
Burdett NG; Menon DK; Carpenter TA; Jones JG; Hall LD
Magn Reson Imaging; 1995; 13(4):549-53. PubMed ID: 7674850
[TBL] [Abstract][Full Text] [Related]
34. Antagonism of metabotropic glutamate receptor type 5 attenuates l-DOPA-induced dyskinesia and its molecular and neurochemical correlates in a rat model of Parkinson's disease.
Mela F; Marti M; Dekundy A; Danysz W; Morari M; Cenci MA
J Neurochem; 2007 Apr; 101(2):483-97. PubMed ID: 17359492
[TBL] [Abstract][Full Text] [Related]
35. The effect of prolonged anesthesia with isoflurane, propofol, dexmedetomidine, or ketamine on neural cell proliferation in the adult rat.
Tung A; Herrera S; Fornal CA; Jacobs BL
Anesth Analg; 2008 Jun; 106(6):1772-7. PubMed ID: 18499608
[TBL] [Abstract][Full Text] [Related]
36. Effects of ketamine/xylazine and isoflurane on rat brain glucose metabolism measured by
Prando S; Carneiro CG; Otsuki DA; Sapienza MT
Eur J Neurosci; 2019 Jan; 49(1):51-61. PubMed ID: 30402917
[TBL] [Abstract][Full Text] [Related]
37. Effects of a combination treatment of KD5040 and
Ahn S; Song TJ; Park SU; Jeon S; Kim J; Oh JY; Jang J; Hong S; Song MA; Shin HS; Jung YR; Park HJ
BMC Complement Altern Med; 2017 Apr; 17(1):220. PubMed ID: 28424060
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic alcohol consumption on brain damage following transient focal ischemia.
Sun H; Zhao H; Sharpe GM; Arrick DM; Mayhan WG
Brain Res; 2008 Feb; 1194():73-80. PubMed ID: 18191819
[TBL] [Abstract][Full Text] [Related]
39. Influence of different anesthetics on skin oxygenation studied by electron paramagnetic resonance in vivo.
Abramovic Z; Sentjurc M; Kristl J; Khan N; Hou H; Swartz HM
Skin Pharmacol Physiol; 2007; 20(2):77-84. PubMed ID: 17143012
[TBL] [Abstract][Full Text] [Related]
40. Targeting β-arrestin2 in the treatment of L-DOPA-induced dyskinesia in Parkinson's disease.
Urs NM; Bido S; Peterson SM; Daigle TL; Bass CE; Gainetdinov RR; Bezard E; Caron MG
Proc Natl Acad Sci U S A; 2015 May; 112(19):E2517-26. PubMed ID: 25918399
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]